Navigation Links
New Findings from Miraca Life Sciences Research Institute Slated for Release at ACG 2013

Irving, Texas (PRWEB) September 25, 2013

Findings from seven research studies conducted by the Miraca Life Sciences Research Institute have been selected for presentation at this year’s American College of Gastroenterology annual scientific meeting. Beginning Sunday, October 13, 2013 through Tuesday, October 15, attendees at the San Diego-based meeting will have an opportunity to review these seven studies, and learn about the specific clinical utility of these investigations to benefit patient care.

Dr. Robert M. Genta, Chief of Academic Affairs at the Miraca Life Sciences Research Institute and a Clinical Professor of Pathology and Gastroenterology at the University of Texas Southwestern Medical Center at Dallas, noted that the studies are based upon data from the company’s extensive repository of histopathologic, demographic and clinical patient information and represent important advancements in patient care.

Dr. Genta said, “With more than 5 million patients in our database, each complete with demographic, endoscopic, and clinical data, we are in a unique position to carry out nation-wide clinicopathologic research projects. The studies reported at this year’s meeting, as well as some studies recently published by Miraca Life Sciences pathologists, are prime examples of the broad cross-section of demographics and disease states that can lie at the foundation of our research endeavors.”

The seven studies by pathologists at Miraca Life Sciences include new insights suggesting that Eosinophilic Esophagitis and inflammatory bowel disease (IBD) may share a common immunopathogenetic mechanism; how the role of HIV infection and CD4 cells affect gastric mucosal response; and strong data supporting the assertion that Helicobacter-negative Chronic Active Gastritis occurs as a distinct condition, unrelated to H. pylori infection.

Another study confirmed the inverse relationship between Eosinophilic Esophagitis (EoE) and H. pylori infection (previously reported by Lash and Genta from Miraca Life Sciences in collaboration with researcher from the University of North Carolina) and expanded the observations to other conditions of the stomach, including autoimmune atrophic gastritis.

The Miraca Research Institute efforts, Dr. Genta says, “address diverse gastroenterological conditions that have widespread prevalence and incur significant burden to an individual’s quality of life, and expense to our health system.”

“It is imperative to develop new approaches in diagnosis and therapy. These can best develop from research that examines large amounts of data for nuances of pathologic relationships that would be undiscoverable in small studies, giving us insights to advance quality care and treatment outcomes in these populations.”

Also to be presented are conclusions from the largest clinicopathologic series of patients with documented spirochetosis, which found that the condition may be asymptomatic in more than half of the subjects infected. Researchers will also discuss the unexpected finding of fungal esophagitis in patients with endoscopically unremarkable esophagus, and how patients with diarrhea and microscopic colitis (MC) have a significantly lower prevalence of colorectal polyps, suggesting inhibition of epithelial proliferation by regulatory T-cells.

About Miraca Life Sciences

Serving more than 3,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.

Miraca Life Sciences, a wholly-owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It is part of our commitment: not only to scientific excellence, but to patients and practices.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Reassuring findings for mothers who have influenza vaccine while pregnant
2. Figurella Announces Findings That Show Their Method Can Fight Cellulite from Inside
3. ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis Research
4. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
5. Pradaxa Lawsuit News: Bernstein Liebhard LLP Comments on Study Findings Regarding Use of Pradaxa in Mechanical Heart Valve Patients
6. Newest Bard IVC Filter Failure Lawsuit Allegations Update: Resource4thePeople Urges Consumers to Review FDA, Research Study Findings about Adverse Events
7. Liquid Grids Releases Findings from Three Case Studies, Validating Direct to Persona Marketing for Healthcare
8. New findings could influence the development of therapies to treat dengue disease
9. Rancid Fish Oil Capsules May Partly Explain Omega-3 and Prostate Cancer Findings, Suggest Co-founders of Omega3 Innovations
10. New study describes imaging findings in H7N9 influenza
11. New Survey Findings: Application Intelligence and Connected Devices - How do you Harness the Value?
Post Your Comments:
(Date:10/13/2015)... ... (PRWEB) October 13, 2015 ... its 2015 annual meeting and corresponding events Oct. 29-31 in ... seminars; a luncheon featuring keynote speaker Air Force Gen. Paul ... the Community Heroes Award Night, which recognizes individuals and groups ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Vision Group Holdings, ... of San Diego, California. With brands including The LASIK Vision Institute and TLC Laser ... it the nationwide leader in laser vision correction. , Global Laser Vision will continue ...
(Date:10/13/2015)... Nashville, Tennessee (PRWEB) , ... October 13, 2015 ... ... owned leader of anesthesia and pain management services, today announced its partnership with ... the partnership integrates data from disparate systems and organizes the data into an ...
(Date:10/13/2015)... ... October 13, 2015 , ... Symposium Chairman, Dr. Rod J. Rohrich ... Cosmetic Symposium to be held March 2nd and 3rd, 2016. The annual meeting, along ... surgeons and cosmetic physicians from around the world. , Key topics at this year's ...
(Date:10/13/2015)... ST. LOUIS and CHENNAI, India (PRWEB) , ... October 13, 2015 ... ... the development of advanced camera solutions, today announced See3CAM_CU40, the industry’s first ... stand-alone MIPI CSI-2 module. See3CAM_CU40, a new member of e-con’s See3CAM family of UVC ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... ) has ... European markets for Meniscal Repair - 16 Countries ... ) has announced the addition of ... Repair - 16 Countries (2010-2021)" report to ... ( ) has announced the addition of ...
(Date:10/13/2015)... , Oct. 13, 2015   Vigilant Biosciences, Inc. ... that aid in the early detection and intervention of ... Vigilant,s founder and CEO, Matthew H.J. Kim , ... which recognizes an entrepreneur who has made extraordinary contributions ... life sciences industry in the leadership of a company ...
(Date:10/13/2015)... , Oct. 13, 2015  EndoChoice Holdings, Inc. ... third quarter 2015 financial results on Thursday, November 5, ... . --> . ... Thursday, November 5, 2015 at 9:00 a.m. ET to ... for domestic callers and (412) 317-5469 for international callers. ...
Breaking Medicine Technology: